Brain-boosting supplement magnesium choline citrate put to the test in healthy volunteers
NCT ID NCT07685613
First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time
Summary
This trial tests whether a dietary supplement called magnesium choline citrate can improve cognitive function and reduce anxiety in healthy adolescents and adults aged 8 and older. Over 84 days, participants take either the supplement or a placebo and complete questionnaires about their thinking skills and anxiety levels. The study aims to see if this simple supplement can offer a safe, everyday way to support mental sharpness and calmness.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- magnesium choline citrate
- What this could lead to
- If it works, this supplement could offer a simple, non-prescription way to support memory and calmness in healthy people.
- What could go wrong
- This is an early-stage, industry-funded trial with subjective questionnaire outcomes. The supplement may show no benefit over placebo, and results may not apply to people with clinical conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Apr 2027
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
8 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Males and females 8 years and older 2. Females not of child-bearing potential, defined as those who have undergone a sterilization procedure (e.g. hysterectomy, bilateral oophorectomy, bilateral tubal ligation, complete endometrial ablation) or have been post-menopausal for at least 1 year prior to screening Or, Individuals of child-bearing potential must confirm negative baseline pregnancy status and agree to use a medically approved method of birth control for the duration of the study. All hormonal birth control must have been in use for a minimum of three months. Acceptable methods of birth control include: * Hormonal contraceptives including oral contraceptives, hormone birth control patch (Ortho Evra), vaginal contraceptive ring (NuvaRing), injectable contraceptives (Depo-Provera, Lunelle), or hormone implant (Norplant System) * Double-barrier method * Intrauterine devices * Non-heterosexual lifestyle and agrees to use contraception if planning on changing to heterosexual partner(s) * Vasectomy of partner at least 6 months prior to screening * Abstinence and agrees to use contraception if planning on becoming sexually active during the study 3. Has recently noticed a worsening in or wishes to improve one or all of the following: 1. Memory 2. Focus 3. Attention \*Participants \<18 years of age will require parent/guardian confirmation of self-perceived worsening in or wishes to improve memory, focus or attention 4. Agrees to maintain current lifestyle habits (diet, physical activity, medications, supplements, and sleep) as much as possible throughout the study 5. Agrees to and self-reports ability to consume study product, and complete all questionnaires, diaries, and assessments required for participation 6. Provided voluntary, written, informed consent to participate in the study 7. Generally healthy as determined by medical history with no unstable diagnosed medical conditions Exclusion Criteria: 1. Individuals who self-report as pregnant, breast feeding, or planning to become pregnant during the study 2. Allergy, sensitivity, intolerance, or dietary restriction preventing consumption of investigational product or placebo ingredients 3. Self-reported ongoing diagnosis of a neuropsychiatric condition and/or cognitive impairment 4. Self-reported ongoing diagnosis with a stress or anxiety disorder 5. Self-reported ongoing and unstable diseases/conditions in the past six months, including: 1. Gastrointestinal diseases 2. Hypertension 3. Type I or type II diabetes 4. Cardiovascular disease 5. Kidney and/or liver diseases 6. Thyroid condition 6. Self-reported major surgery in the past 3 months or individuals who have planned surgery during the course of the study. 7. Self-reported cancer, except skin basal cell carcinoma completely excised with no chemotherapy or radiation with a follow up that is negative. Volunteers with cancer in full remission for more than five years after diagnosis are acceptable 8. Individuals with self-reported autoimmune disease or are immune compromised 9. Alcohol intake average of \>2 standard drinks per day 10. Alcohol or drug abuse within the last 12 months that has required treatment 11. Current use of prescribed and/or over-the-counter (OTC) medications, supplements, and/or consumption of food/drinks that may impact the efficacy and/or safety of the investigational product (Sections 7.3.1 and 7.3.2) 12. Participation in other clinical research studies 30 days prior to baseline 13. Individuals who are unable to give informed consent 14. Any other condition or lifestyle factor that may adversely affect the participant's ability to complete the study or its measures or pose significant risk to the participant
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anxiety are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
KGK Science Inc.
London, Ontario, N5Y 5V6, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Haptic feedback for improved interoceptive awareness and mental well-being: a comprehensive In-the-Wild study for wellness
- The effect of stress ball use during femoral arterial sheath removal after coronary angiography on pain, anxiety, patient satisfaction, and hemodynamic parameters
- The dynamic mechanism of mindfulness intervention for emotional distress (MIED) based on ecological moment measurement
- Project QUIT+: adapting and testing a smoking cessation intervention for transgender and gender expansive individuals
- Interactions between food processing level, nutrition quality, nutrition security and anxiety in israeli adults: influence on dietary intake
- Can listening to music calm anxiety at the end of life?